台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

Case sharing_李高漢

2023-03-03 • 觀看: 16 • 回應: 0 • 影片
Interstitial cystitis/Bladder pain syndrome - Treatment based on individual pathophysiology_郭漢崇

2023-03-03 • 觀看: 48 • 回應: 0 • 影片
Outcome analysis after transurethral resection of prostate_陳思如

2023-03-03 • 觀看: 16 • 回應: 0 • 影片
Prostate cancer risk during BPH medical treatment_李思恩

2023-03-03 • 觀看: 20 • 回應: 0 • 影片
Risk factors associated with prostate abscess management and outcome_楊立宇

2023-03-03 • 觀看: 20 • 回應: 0 • 影片
Comparison of Thulium Laser Enucleation and conventional transurethral resection among BPH patients_謝博彥

2023-03-03 • 觀看: 24 • 回應: 0 • 影片
The effect of 2-carba-cyclic phosphatidic acid on treatment chronic cystitis rats_陳進利

2023-03-03 • 觀看: 14 • 回應: 0 • 影片
Urine Biomarkers in LUTD_江元宏

2023-03-03 • 觀看: 17 • 回應: 0 • 影片
Drug Utilization Patterns in Patients with Lower Urinary Tract Dysfunctions (LUTD) in Taiwan_柳瑞明

2023-03-03 • 觀看: 24 • 回應: 0 • 影片
Mirabegron is more tolerable than solifenacin in Sjogren’s syndrome patients with OAB symptoms_曾浩翔

2023-03-03 • 觀看: 15 • 回應: 0 • 影片
Comparative study between behavior therapy and behavior therapy plus mirabegron 50mg in sexually active men with bothersome OAB symptoms – A multicenter, randomized study_林志杰

2023-03-03 • 觀看: 22 • 回應: 0 • 影片
(IS5-1) Optimizing treatment outcomes with immunotherapy in advanced / metastatic UC_溫聖辰

2023-02-13 • 觀看: 18 • 回應: 0 • 影片

Prev
268
269
270
271
272
273
274
275
276
277
Next
/ 1056